Clinicaltrialvanguard
Published November 18, 2026
Prelude Therapeutics Reports $142.7M Cash as PRT13722 Enters Phase 1
Read the full story at Clinicaltrialvanguard
Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence ... The 8-K itself is procedurally spare: it attaches the Q3 earnings press release.
Surfaced by this Google Alert
- Psychedelic press release